Co-Therapy of Silymarin and Vitamin E Attenuates Doxorubicin-Induced Hepatotoxicity in Rats by Mitigating Oxidative Damage and Preserving Hepatic Architecture. Tikrit J. Pharm. Sci. 2026, 20 (1), 20-32. https://doi.org/10.25130/tjphs.2026.20.1.3.20.32.